In my first article in February, I explained that while accessibility is the right thing to do, it is also the smart thing to do – embracing accessibility provides an opportunity to grow your business through tapping into what we at Be.Lab call ‘the access market’. Here, I look at ways to make simpl
Ocular melanoma (OM) is the most common cancer in the adult eye. OM affects structures in the eye containing melanocytes: the choroid, ciliary body, iris (collectively called the uvea) and the
Alcon has once again expanded its range of preservative-free eye drops with the addition of Systane COMPLETE PRESERVATIVE-FREE Lubricant Eye Drops. This lubricating eye drop combines the long-lasting formulation of Systane COMPLETE with a multi-dose, preservative-free bottle.
The RANZCO Practice Managers’ Conference was the first full online conference I have attended, so I was a little dubious about how it would go. Traveling to Brisbane for a long weekend and networking with likeminded people sounded so much more appealing than giving up a weekend to sit at home with a
I read with interest the article by Wadhwa et al regarding the impact of the Covid-19 pandemic on the eyecare system in Aotearoa-New Zealand. Covid-19 has placed an overwhelming burden on our healthcare system with a major impact on how ophthalmic services operate in New Zealand. Notably, ophthalmol
Non-melanoma skin cancers (NMSCs) are the commonest cancers in Australia and New Zealand. In 2006, the age-standardised incidence of NMSCs was 406 per 100,000 population in New Zealand1. Treatment of NMSCs represents a significant cost to Australasian healthcare systems1,2 and their incidence is ris
Focusing on dry eye disease (DED), the third Ocular Therapeutics Evening (OTE) finally went ahead after a five-month wait. It’s been a while since we had an in-person meeting, so it was great to see at least the top halves of some familiar faces again! It was also entertaining to see the Covid trace
The case study on Parkinson’s disease by Layal Naji (NZ Optics, March 2022*) was a timely reminder of this very common disease that affects an increasing number of our clients, sometimes at a surprisingly young age. I would like to add to its clinical pearls by pointing out that as a neurological di
There is a lot to be grumpy about in our industry.
Having helped develop a new set of 10 internationally recognisable and simplified optotypes to improve visual acuity (VA) checks for young children, vision researcher Dr Lisa Hamm admits to being a little fixated by optotype choice. Here she shares that passion with a short guide to the evolution of
Pseudoexfoliation syndrome (PXF) is important to identify as it carries a significant risk of glaucoma. Once pseudoexfoliative glaucoma develops, it may run an aggressive course requiring close monitoring and intensive treatment to prevent significant visual loss.